Insider Transactions in Q4 2020 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2020
|
Stephen A Sherwin Director |
SELL
Bona fide gift
|
Direct |
2,806
-9.4%
|
-
|
|
Dec 01
2020
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,645
-12.52%
|
$154,630
$94.66 P/Share
|
|
Nov 12
2020
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,257
-18.39%
|
$203,130
$90.74 P/Share
|
|
Nov 12
2020
|
Haig P. Bozigian Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,257
-1.46%
|
$203,130
$90.74 P/Share
|
|
Nov 12
2020
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,257
-16.31%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Kyle Gano Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,257
-2.25%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Kevin Charles Gorman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,390
-0.76%
|
$305,100
$90.78 P/Share
|
|
Nov 12
2020
|
Dimitri E. Grigoriadis Chief Research Officer |
SELL
Open market or private sale
|
Direct |
2,257
-2.69%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,257
-6.98%
|
$203,130
$90.72 P/Share
|
|
Nov 12
2020
|
Malcolm Lloyd Smith Chief Integration Officer |
SELL
Open market or private sale
|
Direct |
2,257
-7.22%
|
$203,130
$90.73 P/Share
|
|
Nov 12
2020
|
Eiry Roberts Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,257
-14.34%
|
$203,130
$90.74 P/Share
|
|
Nov 12
2020
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,257
-11.48%
|
$203,130
$90.71 P/Share
|
|
Nov 02
2020
|
Eric Benevich Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
20,595
-57.26%
|
$1,977,120
$96.53 P/Share
|
|
Nov 02
2020
|
Eric Benevich Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,595
+36.41%
|
$720,825
$35.99 P/Share
|
|
Oct 02
2020
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
987
-9.37%
|
$93,765
$95.26 P/Share
|